Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$102.21 - $122.25 $562,155 - $672,375
-5,500 Reduced 38.46%
8,800 $1.03 Million
Q1 2024

May 15, 2024

BUY
$105.2 - $126.4 $589,120 - $707,840
5,600 Added 64.37%
14,300 $1.79 Million
Q4 2023

Feb 14, 2024

BUY
$76.46 - $101.74 $22,937 - $30,522
300 Added 3.57%
8,700 $885,000
Q3 2023

Nov 14, 2023

SELL
$88.53 - $107.13 $106,236 - $128,556
-1,200 Reduced 12.5%
8,400 $743,000
Q2 2023

Aug 14, 2023

SELL
$87.79 - $109.66 $403,834 - $504,436
-4,600 Reduced 32.39%
9,600 $960,000
Q1 2023

May 15, 2023

BUY
$85.05 - $114.38 $612,360 - $823,536
7,200 Added 102.86%
14,200 $1.36 Million
Q4 2022

Feb 14, 2023

SELL
$85.14 - $125.74 $570,438 - $842,458
-6,700 Reduced 48.91%
7,000 $803,000
Q3 2022

Nov 14, 2022

SELL
$84.44 - $116.86 $33,776 - $46,744
-400 Reduced 2.84%
13,700 $1.16 Million

Others Institutions Holding CURE

About DIREXION DAILY HEALTHCARE BULL


  • Ticker CURE
  • Sector ETFs
  • Industry ETFs
More about CURE
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.